Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
11%
Ph phase_1
2
22%
Ph phase_4
2
22%
Ph phase_2
2
22%
Ph not_applicable
2
22%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Completed(1)
Other(2)

Detailed Status

Not yet recruiting3
Recruiting3
unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 42 (22.2%)
N/A2 (22.2%)

Trials by Status

not_yet_recruiting333%
completed111%
recruiting333%
unknown222%

Recent Activity

3 active trials
Showing 5 of 9
not_yet_recruitingphase_3

THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL

NCT07813767
recruitingphase_2

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

NCT07059091
recruitingnot_applicable

Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis

NCT07188766
recruitingphase_4

The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

NCT07359599
not_yet_recruitingnot_applicable

Intertransverse Process Block to Improve Quality of Recovery After Cardiac Surgery With Sternotomy

NCT06926764
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07813767Phase 3

THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL

Not Yet Recruiting
NCT07059091Phase 2

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Recruiting
NCT07188766Not Applicable

Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis

Recruiting
NCT07359599Phase 4

The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

Recruiting
NCT06926764Not Applicable

Intertransverse Process Block to Improve Quality of Recovery After Cardiac Surgery With Sternotomy

Not Yet Recruiting
NCT05441410Phase 1

Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults

Not Yet Recruiting
NCT05554978Phase 1

Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

Unknown
NCT05289050Phase 4

Analgesic Effect of Intraoperative Intravenous S-Ketamine During Total Knee Arthroplasty Surgery

Unknown
NCT00650143Phase 2

Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9